Quadcap Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Quadcap Wealth Management's VRTX Position: Q2 2026 in Review
Quadcap Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.21% in Q2 2026, buying an estimated $1.77K and bringing the position to 1,895 shares worth $941K. The position accounts for 0.09% of the portfolio, ranked #180.
Quadcap Wealth Management first reported a position in VRTX in Q3 2025 and has held it in 4 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Quadcap Wealth Management held 1,895 shares of Vertex Pharmaceuticals worth $941K as of Q2 2026.
- Quadcap Wealth Management bought 4 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.77K.
- Vertex Pharmaceuticals made up 0.09% of Quadcap Wealth Management's portfolio in Q2 2026, its #180 holding.
- Quadcap Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.